Palvella Therapeutics (PVLA) Depreciation and Depletion (2014 - 2020)
Palvella Therapeutics' (PVLA) quarterly Depreciation and Depletion came in at $530000.0 in Q2 2020, up 1161.9% year-on-year from $42000.0 in Q3 2019, and up 56.34% on a QoQ basis from $339000.0 in Q1 2020.
Palvella Therapeutics (PVLA) Depreciation and Depletion (2014 - 2020) Analysis & Trends
Palvella Therapeutics (PVLA) has 7 years of Depreciation and Depletion data on file, last reported at $530000.0 in Q2 2020.
- On a quarterly basis, Depreciation and Depletion rose 1161.9% year-over-year to $530000.0 in Q2 2020; TTM through Jun 2020 was $1.3 million, a 136.59% increase from a year earlier, with the FY2023 full-year figure at $1.8 million, down 21.74% from the prior year.
- Depreciation and Depletion for Q2 2020 stood at $530000.0, up from $339000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for PVLA reached as high as $530000.0 in Q2 2020 and fell as low as -$11764.0 in Q2 2016.
- Historically, Depreciation and Depletion has averaged $157666.7 across 5 years, with a median of $132000.0 in 2018.
- Across the five-year window, Depreciation and Depletion plunged 115.39% in 2016 and jumped 1161.9% in 2020, its largest moves.
- Year by year, Depreciation and Depletion stood at $224613.0 in 2016, then tumbled by 55.03% to $101000.0 in 2017, then jumped by 93.07% to $195000.0 in 2018, then rose by 19.49% to $233000.0 in 2019, then surged by 127.47% to $530000.0 in 2020.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $530000.0 in Q2 2020, $339000.0 in Q1 2020, and $233000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 530,000.00 |
| Jun 30, 2020 | 530,000.00 |
| Mar 31, 2020 | 339,000.00 |
| Mar 31, 2020 | 339,000.00 |
| Dec 31, 2019 | 233,000.00 |
| Dec 31, 2019 | 233,000.00 |
| Sep 30, 2019 | 159,000.00 |
| Sep 30, 2019 | 159,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Mar 31, 2019 | 166,000.00 |
| Mar 31, 2019 | 166,000.00 |
| Dec 31, 2018 | 195,000.00 |
| Dec 31, 2018 | 195,000.00 |
| Sep 30, 2018 | 130,000.00 |
| Sep 30, 2018 | 130,000.00 |
| Jun 30, 2018 | 141,000.00 |
| Jun 30, 2018 | 141,000.00 |
| Mar 31, 2018 | 134,000.00 |
| Mar 31, 2018 | 134,000.00 |